Skip to content

Nasdaq · CIK 0001484612

OM Outset Medical, Inc.

Insider trading from SEC Form 4. Last filing 7 d ago. Close $4.05 on Oct 9, 2026, +37% from the 52-week low and -74% from the high.

Last 90 days

Net insider value
+$870k
more bought than sold
Buys
1
$870k by 1 insider
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company

Price and insider trades, last year

OMOct 9, 2026 · close 4.05

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Outset Medical, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
41ModerateBraden Michael Leonard
owner
buy
$870k
244,909 shares
+10%+27% from low-76% from high
30WeakJohn L. Brottem
General Counsel
sell
$4,933
383 shares
-1%+97% from low-37% from high
30WeakMarc Nash
SVP Operations and R&D
sell
$3,130
243 shares
-1%+97% from low-37% from high
40ModerateLeslie Trigg
Chair and CEO
sell
$12k
904 shares
-1%+97% from low-37% from high
37WeakNabeel Ahmed
Chief Financial Officer
sell
$10k
584 shares
-4%+190% from low-7% from high
30WeakJohn L. Brottem
General Counsel
sell
$7,057
396 shares
-3%+190% from low-7% from high
30WeakMarc Nash
SVP Operations and R&D
sell
$4,491
252 shares
-2%+190% from low-7% from high
40ModerateLeslie Trigg
Chair and CEO
sell
$17k
935 shares
-2%+190% from low-7% from high
30WeakNabeel Ahmed
Chief Financial Officer
sell
$7,793
8,659 shares
-3%+102% from low-35% from high
23WeakJohn L. Brottem
General Counsel
sell
$5,531
6,145 shares
-3%+102% from low-35% from high
40ModerateNabeel Ahmed
Chief Financial Officer
sell
$27k
34,288 shares
-12%+79% from low-42% from high
33WeakJohn L. Brottem
General Counsel
sell
$26k
32,930 shares
-15%+79% from low-42% from high
30WeakNabeel Ahmed
Chief Financial Officer
sell
$24k
29,031 shares
-9%+80% from low-42% from high
23WeakJohn L. Brottem
General Counsel
sell
$17k
20,492 shares
-9%+80% from low-42% from high
30WeakNabeel Ahmed
Chief Financial Officer
sell
$2,367
1,835 shares
-1%+144% from low-21% from high
23WeakJohn L. Brottem
General Counsel
sell
$2,028
1,572 shares
-1%+144% from low-21% from high
37WeakNabeel Ahmed
Chief Financial Officer
sell
$3,377
4,221 shares
-1%-
30WeakJohn L. Brottem
General Counsel
sell
$2,562
3,203 shares
-1%-
30WeakMarc Nash
SVP Operations and R&D
sell
$1,100
1,375 shares
-1%-
40ModerateLeslie Trigg
Chair and CEO
sell
$4,516
5,645 shares
-1%-

Transactions

The last 57 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026Braden Michael Leonard
owner
POpen-market purchase
Common Stockindirect: Holdings of BML Investment Partners, L.P.
+228,334$3.53$806k2,748,0357 d ago
Oct 2, 2026Braden Michael Leonard
owner
POpen-market purchase
Common Stockindirect: Holdings of BML Investment Partners, L.P.
+16,575$3.88$64k2,764,6107 d ago
Aug 25, 2025Marc Nash
EVP, R&D, Operations and Serv.
AGrant or award
Common Stock
+5,617$0.00$048,515Aug 25, 2025
Aug 15, 2025John L. Brottem
General Counsel
SOpen-market sale
Common Stock
-383$12.88$4,93346,883Aug 18, 2025
Aug 15, 2025Marc Nash
SVP Operations and R&D
SOpen-market sale
Common Stock
-243$12.88$3,13042,898Aug 18, 2025
Aug 15, 2025Leslie Trigg
Chair and CEO
SOpen-market sale
Common Stock
-904$12.88$12k122,328Aug 18, 2025
Jun 10, 2025Leslie Trigg
Chair and CEO
AGrant or award
Common Stock
+65,103$0.00$0123,232Jun 11, 2025
Jun 10, 2025Marc Nash
SVP Operations and R&D
AGrant or award
Common Stock
+29,676$0.00$043,141Jun 11, 2025
Jun 10, 2025Renee Gaeta
Chief Financial Officer
AGrant or award
Common Stock
+131,425$0.00$0131,425Jun 11, 2025
Jun 10, 2025John L. Brottem
General Counsel
AGrant or award
Common Stock
+35,993$0.00$047,266Jun 11, 2025
Jun 2, 2025Karen Drexler
director
AGrant or award
Common Stock
+8,983$0.00$012,198Jun 4, 2025
Jun 2, 2025D Keith Grossman
director
AGrant or award
Common Stock
+8,983$0.00$013,918Jun 4, 2025
Jun 2, 2025Patrick T Hackett
director
AGrant or award
Common Stock
+8,983$0.00$095,172Jun 4, 2025
Jun 2, 2025Brent D. Lang
director
AGrant or award
Common Stock
+8,983$0.00$017,851Jun 4, 2025
Jun 2, 2025Kevin C Oboyle
director
AGrant or award
Common Stock
+8,983$0.00$024,118Jun 4, 2025
Jun 2, 2025Andrea Lynn Saia
director
AGrant or award
Common Stock
+8,983$0.00$012,175Jun 4, 2025
May 15, 2025John L. Brottem
General Counsel
SOpen-market sale
Common Stock
-396$17.82$7,05711,273May 16, 2025
May 15, 2025Leslie Trigg
Chair and CEO
SOpen-market sale
Common Stock
-935$17.80$17k58,129May 16, 2025
May 15, 2025Marc Nash
SVP Operations and R&D
SOpen-market sale
Common Stock
-252$17.82$4,49113,465May 16, 2025
May 15, 2025Nabeel Ahmed
Chief Financial Officer
SOpen-market sale
Common Stock
-584$17.81$10k16,096May 16, 2025
May 14, 2025Kevin C Oboyle
director
AGrant or award
Common Stock
+15,135$0.00$015,135May 14, 2025
Mar 10, 2025Karen Drexler
director
MOption exercise
Common Stockindirect: Drexler Family Trust
+31,250--31,250Mar 11, 2025
Mar 10, 2025D Keith Grossman
director
MOption exercise
Common Stockindirect: Grossman Fam Trust
+187,500--192,686Mar 11, 2025
Mar 10, 2025Brent D. Lang
director
MOption exercise
Common Stockindirect: Lang Family Trust
+250,000--250,000Mar 11, 2025
Mar 10, 2025Patrick T Hackett
director
MOption exercise
Common Stock
+1,250,000--1,292,849Mar 11, 2025
Mar 10, 2025Patrick T Hackett
director
MOption exercise
Common Stockindirect: GST Trust
+1,250,000--1,250,000Mar 11, 2025
Mar 7, 2025D Keith Grossman
director
AGrant or award
Series A Non-Voting Convertible Preferredderivativeindirect: Grossman Fam Trust
+750$200.00$150k750Mar 11, 2025
Mar 7, 2025Karen Drexler
director
AGrant or award
Series A Non-Voting Convertible Preferredderivativeindirect: Drexler Family Trust
+125$200.00$25k125Mar 11, 2025
Mar 7, 2025Brent D. Lang
director
AGrant or award
Series A Non-Voting Convertible Preferredderivativeindirect: Lang Family Trust
+1,000$200.00$200k1,000Mar 11, 2025
Mar 10, 2025Patrick T Hackett
director
MOption exercise
Common Stockindirect: Hackett Family Fund
+625,000--625,000Mar 11, 2025
Mar 7, 2025Patrick T Hackett
director
AGrant or award
Series A Non-Voting Convertible Preferredderivative
+5,000$200.00$1.0M5,000Mar 11, 2025
Mar 10, 2025D Keith Grossman
director
MOption exercise
Series A Non-Voting Convertible Preferredderivativeindirect: Grossman Fam Trust
-750$0.00$00Mar 11, 2025
Mar 10, 2025Brent D. Lang
director
MOption exercise
Series A Non-Voting Convertible Preferredderivativeindirect: Lang Family Trust
-1,000$0.00$00Mar 11, 2025
Mar 10, 2025Karen Drexler
director
MOption exercise
Series A Non-Voting Convertible Preferredderivativeindirect: Drexler Family Trust
-125$0.00$00Mar 11, 2025
Mar 10, 2025Patrick T Hackett
director
MOption exercise
Series A Non-Voting Convertible Preferredderivative
-5,000$0.00$00Mar 11, 2025
Mar 7, 2025Patrick T Hackett
director
AGrant or award
Series A Non-Voting Convertible Preferredderivativeindirect: GST Trust
+5,000$200.00$1.0M5,000Mar 11, 2025
Mar 10, 2025Patrick T Hackett
director
MOption exercise
Series A Non-Voting Convertible Preferredderivativeindirect: GST Trust
-5,000--0Mar 11, 2025
Mar 7, 2025Patrick T Hackett
director
AGrant or award
Series A Non-Voting Convertible Preferredderivativeindirect: Hackett Family Fund
+2,500$200.00$500k2,500Mar 11, 2025
Mar 10, 2025Patrick T Hackett
director
MOption exercise
Series A Non-Voting Convertible Preferredderivativeindirect: Hackett Family Fund
-2,500$0.00$00Mar 11, 2025
Feb 18, 2025Nabeel Ahmed
Chief Financial Officer
SOpen-market sale
Common Stock
-8,659$0.90$7,793250,210Feb 19, 2025
Feb 18, 2025John L. Brottem
General Counsel
SOpen-market sale
Common Stock
-6,145$0.90$5,531175,043Feb 19, 2025
Jan 17, 2025John L. Brottem
General Counsel
AGrant or award
Common Stock
+9,090$0.00$0214,118Jan 22, 2025
Jan 17, 2025Nabeel Ahmed
Chief Financial Officer
AGrant or award
Common Stock
+13,256$0.00$0293,157Jan 22, 2025
Jan 21, 2025Nabeel Ahmed
Chief Financial Officer
SOpen-market sale
Common Stock
-907$0.80$726292,250Jan 22, 2025
Jan 21, 2025John L. Brottem
General Counsel
SOpen-market sale
Common Stock
-777$0.80$622213,341Jan 22, 2025
Jan 21, 2025Nabeel Ahmed
Chief Financial Officer
SOpen-market sale
Common Stock
-29,474$0.80$24k262,776Jan 22, 2025
Jan 21, 2025John L. Brottem
General Counsel
SOpen-market sale
Common Stock
-29,474$0.80$24k183,867Jan 22, 2025
Jan 21, 2025John L. Brottem
General Counsel
SOpen-market sale
Common Stock
-2,679$0.80$2,143181,188Jan 22, 2025
Jan 21, 2025Nabeel Ahmed
Chief Financial Officer
SOpen-market sale
Common Stock
-3,907$0.80$3,126258,869Jan 22, 2025
Jan 13, 2025Nabeel Ahmed
Chief Financial Officer
SOpen-market sale
Common Stock
-29,031$0.81$24k279,901Jan 13, 2025
Jan 13, 2025John L. Brottem
General Counsel
SOpen-market sale
Common Stock
-20,492$0.81$17k205,028Jan 13, 2025
Jan 7, 2025Nabeel Ahmed
Chief Financial Officer
SOpen-market sale
Common Stock
-1,835$1.29$2,367308,932Jan 7, 2025
Jan 7, 2025John L. Brottem
General Counsel
SOpen-market sale
Common Stock
-1,572$1.29$2,028225,520Jan 7, 2025
Nov 15, 2024Nabeel Ahmed
Chief Financial Officer
SOpen-market sale
Common Stock
-4,221$0.80$3,377310,767Nov 18, 2024
Nov 15, 2024John L. Brottem
General Counsel
SOpen-market sale
Common Stock
-3,203$0.80$2,562227,092Nov 18, 2024
Nov 15, 2024Marc Nash
SVP Operations and R&D
SOpen-market sale
Common Stock
-1,375$0.80$1,100238,022Nov 18, 2024
Nov 15, 2024Leslie Trigg
Chair and CEO
SOpen-market sale
Common Stock
-5,645$0.80$4,516904,851Nov 18, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

OM insider trading: Outset Medical, Inc. | InsiderTell